A detailed history of Savant Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, Savant Capital, LLC holds 106,332 shares of OGN stock, worth $1.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
106,332
Previous 104,569 1.69%
Holding current value
$1.64 Million
Previous $2.16 Million 6.01%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$18.65 - $23.03 $32,879 - $40,601
1,763 Added 1.69%
106,332 $2.03 Million
Q2 2024

Aug 05, 2024

BUY
$17.45 - $21.96 $187,046 - $235,389
10,719 Added 11.42%
104,569 $2.16 Million
Q1 2024

May 03, 2024

BUY
$13.78 - $18.8 $1.29 Million - $1.76 Million
93,850 New
93,850 $1.76 Million
Q3 2023

Nov 06, 2023

BUY
$16.59 - $23.77 $214,906 - $307,916
12,954 New
12,954 $224,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.93B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.